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Five immunochemical assays for determin- 
ing low concentrations of albumin were inves- 
tigated. These were a radioimmunoassay 
(RIA); turbidimetric immunoassays (TIA) both 
according to end-point measuring principle 
on a Cobas Fara and Hitachi 71 7 analysers, 
and according to kinetic measuring principle 
on a Turbitimer instrument; and a nephelo- 
metric immunoassay (NIA). All achieved the 
analytical goal necessary for optimal patient 
care. The correlations between the albumin 
concentrations measured with the different 
techniques were very good. In vitro glycation 
of albumin did not influence albumin concen- 
trations measured by the five assays. Urine 
albumin excretion measured over 3 consec- 
utive days showed considerable day-to-day 
variation. This was highest for spot-urine spec- 
imens and significantly lower for 24 h and 
timed-overnight samples. Variation of storage 
temperature (room temperature, 4"C, - 20°C), 
time (up till 3 months), and pH (within the 
range pH 5-8) of the urine samples did not 
change significantly the measured albumin 
concentrations. Different sample preparations 
(vortex-mixing, centrifugation, and thawing) 
had no influence on the measured albumin 
concentration. In conclusion, a maximum stan- 
dardization of the collection of timed-overnight 
urine samples for screening and 24 h urine 
samples for confirmation of microalbuminuria 
during 3 consecutive days is more crucial than 
the choice of the immunological technique. 
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iNTRODUCTlON 
Microalbuminuria both in type 1 (insulin-dependent) and 
type 2 (non-insulin-dependent) diabetic patients has been 
shown to predict increased mortality, not only from re- 
nal origin but also from cardiovascular disease (1-3). 
Therefore screening of diabetic patients for microalbu- 
minuria has become part of routine diabetes care (4). 
However, there is still some discussion about which urine 
sample should be measured (5). To compare various studies 
is difficult, because not only different methods of speci- 
men collection are used, but also different sample-hand- 
ling, assay conditions, and expression of urine albumin 
excretion (6-16). Therefore this study was undertaken 
to compare the usefulness of different methods of speci- 
men collection (24 h collection, timed-overnight speci- 
men, first-morning sample, and spot-urine specimen) in 
the same diabetic patients during 3 consecutive days. 
In addition, the influence of sample handling (storage 
temperature, time, pH, and sample preparation) and tech- 
nique of determination was studied in urine of diabetic 
patients. In an attempt to explain some contradictions 
from the literature the influence of in vitro glycation 
of albumin on the microalbumin determination was investi- 
gated separately. 
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MATERiALS AND METHODS 
Assays 
Microalbuminuria was determined with the following immu- 
noassays: a) Radioimmunoassay (RIA): Albumin Double Anti- 
body RIA Kit, Diagnostic Products Corp., Los Angeles, CA; 
b) Turbidimetric Immunoassay (TIA): according to the end- 
point measuring principle with antisera purchased from Orion 
Diagnostica, Espoo, Finland don a Cobas Fara centrifugal 
analyser (Hoffman-La Roche, Basel, Switzerland) and with 
antisera from Boehringer Mannheim Gmbh., Germany (Tina- 
quant Albumin kit) on a Hitachi 717 analyser; furthermore 
according to kinetic measurement principle by using Turbiquant 
Albumin Kit on a Turbitimer instrument (Behringwerke AG, 
Marburg, Germany); and c) Nephelometric Immunoassay 
(NIA) by using Behring Reagent Kit on a Laser Nephelometer 
(Behringwerke AG, Marburg, Germany). All these assays were 
performed according to the instructions of the manufacturers. 
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In Vitro Glycation of Albumin 
Human serum albumin (HSA) and fresh frozen plasma 
(FFP) samples were incubated for 11 days at room tempera- 
ture with 0.5 M glucose in the presence of 1 g/L sodium azide 
by continuous rotation. Thereafter the samples were dialysed 
against destillated water for 48 h at 4°C (dialysis tubing, Sigma 
Chemical Co., St. Louis, MO). After dialysis the glucose 
concentration was < 0.1 mmoVL. The fructosamine concen- 
trations were 132 and 57 kmol/L before glycation and 1134 
and 335 pmol/L after glycation measured in HSA and FFP 
samples, respectively. 
Specimen Collection 
Timed-overnight urine specimen were collected from 296 
type 1 and type 2 diabetic patients consecutively attending 
the outpatient diabetic clinic. The albumin concentrations of 
all collections were separately measured with the four immu- 
noassays and the results were expressed as mg/L. 
In addition, eight patients with known microalbuminuria 
were asked to collect all urine samples during 3 consecutive 
days. No patients were older than 60 years. They were free 
of major systemic complications of diabetes and of overt kid- 
ney disease. Patients were asked to avoid vigorous exercise 
during the time of collection, and they received detailed writ- 
ten and verbal instruction about the collection. Urine was col- 
lected in plastic containers without additive. Collections began 
immediately after an initial evening void at bedtime, the time 
of which was recorded. All urine produced overnight was col- 
lected in a separate plastic bottle on which the patient recorded 
the beginning and ending-times (Timed-overnight urine spec- 
imen). The morning sample was collected in a separate con- 
tainer and the time of the void was also noted. The first sample 
after the morning specimen was collected in a third bottle 
(Spot-urine specimen). All urine during the day was collected 
in a fourth container. The patients were asked to store the 
bottles with urine on a cool place until the delivery of the 
four containers to the outpatient clinic the morning after the 
collection. The volumes of all collections were separately mea- 
sured and aliquots were prepared. The 24 h specimen was a 
combination of all samples collected during the 24 h period 
and corrected in volume and time. All of these samples were 
measured with the TIA method on a Cobas Fara analyser. 
Albumin excretion rate (AER) was expressed as mg albu- 
mid24 h for a 24 h sample and kg albumidmin for a timed- 
overnight sample, and the albumin Concentration in a spot-Urine 
sample as mg albumin/mmol creatinine. 
Sample Handling 
Aliquots were stored at room temperature for 7 days, at 
4°C for 3 weeks and at - 20°C for 3 months. Determinations 
with the TIA method on a Cobas Fara analyser were done 
after different time intervals as indicated in Figure 3. The speci- 
mens were vortex-mixed and centrifuged (1500g, 10 min) 
before assay. In a second series of aliquots the pH of the urine 
samples was adjusted to pH 4, 5, 6, 7, and 8. Aliquots were 
stored at - 20°C and analysed 0, 1, and 4 weeks after adjust- 
ment. These results were compared with albumin concen- 
trations obtained with fresh unadjusted samples. A third series 
of aliquots was kept at - 20°C for a maximum of 7 days, but 
the samples were equilibrated daily to room temperature and 
either vortex-mixed or vortex-mixed and centrifuged. Mea- 
surements of all 12 samples were done on day 0 and on day 7. 
Data Evaluation and Statistical Methods 
Sensitivity (lower detection limit) was defined as the albu- 
min concentration corresponding to the response of the mean 
+ 2 SD response of the zero standard, determined by repli- 
cate analysis (n = 20). Intrer-assay precision (CV) was esti- 
mated by measuring control samples in duplicate at three 
concentrations in ten runs. Intra-assay precision (CV) was 
calculated by replicate analysis (n = 20) of the control Sam- 
ples at three concentrations in one run. Analytical recoveries 
were estimated by serial dilutions of the standards, and the 
percentage recoveries were calculated. Method comparisons 
were performed using regression analysis according to Pass- 
ing and Bablok (17). 
RESULTS 
Assay Characteristics 
The five assays showed approximately the same order of 
analitical sensitivity (Table 1). The working-ranges varied sig- 
nificantly. The large dynamic range makes TIA-assays more 
easy to perform but has no consequences for their analytical 
performance. Intra- and inter-assay precisions and analytical 
recoveries were comparable for all methods (Table 1). 
Method Comparisons 
The correlations between the albumin concentrations mea- 
sured with the different techniques were very good (Fig. l )  
(r=0.985, 0.994, 0.997, and 0.904 Cobas Fara vs. RIA, 
Hitachi 717, Turbitimer, and NIA, respectively). Owing to 
the practical advantages of the TIA method performed on a 
Cobas Fara analyser (operating cost and technical skill), all 
routine measurements were performed according to this 
method. 
Effect of Glycation 
There were no significant differences when untreated or 
glycated albumine samples were measured with all five assays 
(Table 2). 
Effect of Sample-Choice 
Urine albumine excretion measured over 3 consecutive 
days showed considerable day-to-day variations in each patient 
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TABLE 1. Comparison of the Analytical Performance of Different Microalbumine Assays 
TIA 
Cobas Fara Hitachi Turbitimer NIA RIA 
Sensitivity (mg/L) 2.5 3 3 0.2 0.5 
(n = 20) 
(n = 10) 
Intra-assay (n = 20) 
Working range (mg/L) 2.5-80 3-400 3-3,500 0.2-54 0.5-60 
Precision (CV), % 
Low levela 3.5 5.5 2.5 3.3 2.9 
Intermediateb 1.8 1.5 1.4 1.7 3.2 
High level' 2.4 1.1 1.4 3.1 2.8 
Low levela 7.4 10.3 8.0 8.0 3.5 
Intermediateb 3.7 1.7 5.1 3.2 2.7 
High level' 2.4 2.4 7.4 2.9 2.3 
Inter-assay (n = 10) 
Anal. recovery, % 96-105 92- 102 88-104 98-104 96-102 
aLow level: 4-6 mg/L. 
bIntermediate level: 30-35 mg/L. 
'High level: 170-200 mg/L. 
Fig. 2). The highest biological day-to-day variation was 
observed when spot urine specimens were measured (CV 34%). 
The day-to-day CV was significantly lower when albumin excre- 
tion was measured in 24 h and timed-overnight samples (CV 
of 14% and 19%, respectively). 
Effect of Sample-Handling 
analyser because we found this assay inexpensive, simple, 
and rapid to perform, and it fits into our laboratory organi- 
sation. The choice of the sample and the way of the handling 
of the sample is much more disputable (6-16). There is a 
general agreement that 24 h collection is the most reliable 
specimen to confirm the presence of microalbuminuria 
(6,14,16). However our results, obtained by collecting urine 
Storage time and temperature did not have a significant influ- 
ence on measured albumin concentration (Fig. 3). There was 
no difference between albumin concentrations measured 
freshly or after pH adjustment between pH 5 to 8.  This holds 
true both for the directly measured samples and those assayed 
after 1 and 4 weeks. Only adjustment to pH 4 caused a sig- 
nificant decrease (36% and 43% after 1 and 4 weeks, respec- 
tively) in the measured albumin concentrations (Fig. 4). 
Different sample preparations did not have significant influ- 
ence on the measured albumin concentration when urine sam- 
ples (N = 12) were directly measured (21.9 & 12.6 mg/L) or 
stored at - 20°C for 7 days (22.0 k 12.7 mg/L) or stored at 
-20°C but daily thawed during a week, vortex-mixed and 
analysed directly (23.1 * 12.8 mg/L) or after centrifugation 
(23.5 k 13.0mg/L). 
DISCUSSION 
Immunological assays are used to measure low concentra- 
tions of albumin in urine because dye-binding or protein pre- 
cipitation techniques are insensitive and nonspecific. All five 
immunological assays tested here achieved the analytical goal 
necessary for optimal patient care (6). On basis of analytical 
evaluation there is no reason to reject one of them and a choice 
can be made based on practical points (operational costs, 
required technical skill, and logistics). Our choice was an 
end-point TIA measurement performed on a Cobas Fara 
- 
during 3 consecutive days, emphasize the need for repeated 
collection and measurement of AER even with 24 h specimens. 
The same holds true when timed-overnight sample collec- 
tion is used. In accordance with literature (14,16) we found 
correlation between 24 h and overnight collected samples but 
the mean levels of the same patients were lower in the over- 
night collected samples. This may be a result of posture, exer- 
cise, diet, etc. during the day-time. Therefore, theoretically, 
the timed-overnight urine sample is the most reliable speci- 
men to follow microalbuminuria in diabetic patients. How- 
ever, the measured results do not support this view (Fig. 2) 
(14,16). Both collection techniques are inconvenient for patients 
and both methods are dependent of the accuracy of the patient. 
Timed-overnight urine collection is very sensitive to a wrong 
notition of time, but throwing away a sample happens rarely. 
On the contrary, 24 h urine sample is less sensitive to time 
but the loss of a part of the collection is greater, because the 
patient forgets the collection during the day. Therefore, the 
spot-urine sample is potentially interesting as an alternative 
(8). However the very high day-to-day variation in spot-urine 
samples implies that interpretation of these results does require 
caution. 
Urine is often stored at room temperature or at 4°C for a 
few days by the patient or at - 20°C for long periods by the 
laboratory. However the literature shows contradictory reports 
on the effects of storage temperature, time, and other vari- 
ables in sample-handling. A number of publications showed 
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tion coefficients are given in the text. 
Correlation between the five immunochemical measurements of urine albumin concentration. Correla- 
a significant decrease of albumin concentration in frozen sam- 
ples (1 1,13, IS), while others did not find significant effects 
(9,12). Storage at room temperature for I week or at 4°C for 
3 weeks caused no significant changes (13,15). It has been 
suggested also that urine pH is important in the formation of 
precipitate leading to a decreased albumin concentration in 
urine samples (10). However we and others (1 1,13) did not 
find any effect of pH in the normal clinical range. The same 
controversy can be seen on sample preparation such as thaw- 
ing, vortex-mixing, and centrifugation (5,9,10,12). We did 
not find a significant influence of these technical manipula- 
tions on measured microalbuminuria. 
One could speculate that these technical discrepancies are 
due to the heterogeneity of urine albumin present in diabetic 
patients (18). It is well documented in literature that the pro- 
tein composition in urine of patients with diabetes mellitus 
is different due to the non-enzymatic glycation of protein 
(19,20). Glycation of a protein could change the specific 
epitope of the molecule responsible for the antigen-antibody 
specificity. In addition, glycation could be altered by stor- 
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TABLE 2. Effect of Glycation on the Measured Albumin Concentrations With Five Different Assaysa 
500 
400 
- 
r 
* 
300 - 
z 
0 
W g 200. 
W 
z 
5 
4' 100 
Albumin concentration (me/L) 
TIA 
Cobas Fara Hitachi Turbitimer NIA RIA 
Human Serum Albumin 
Untreated 51.6 58.3 49.6 51.8 46.1 
Glycated 49.8 60.3 50.3 52.6 49.8 
Untreated 18.1 21.4 15.8 22.4 15.5 
Glycated 20.1 23.6 16.6 21.7 14.0 
Fresh Frozen Plasma 
"Results are means of four measurements. 
age, sample-handling, etc. Therefore, we compared five immu- 
noassays with five different antisera to measure HSA and FFP 
samples before and after in vitro non-enzymatic glycation 
(Table 2). We did not find significant differences in the mea- 
sured albumin concentrations between the glycated and the 
non-glycated samples, although the fructosamine concentra- 
tions as an indication of the glycated albumin increased approx- 
imately by a factor of 2.5. 
In conclusion, based on the results presented here, timed- 
overnight-urine collection during 3 consecutive days is our 
choice to screen microalbuminuria in diabetic patients. We 
prefer 24 h samples collected during 3 consecutive days to 
confirm the observation. The relatively high day-to-day vari- 
ation during both ways of collection emphasize the need for 
maximum standardization of the collection (exercise, diet, 
etc.). It is preferable to measure albumin within 3 weeks when 
urine is stored at 4"C, but it can also be done within 3 months 
if urine is stored at - 20°C. Sample preparation such as pH 
(between pH 5 3 ,  vortex-mixing, and centrifugation did not 
influence the measured microalbuminuria, but in practice max- 
imum technical standardization is preferable. According to 
our observations, a maximum standardization of the collec- 
tion of timed-overnight urine samples for screening and 24 h 
urine samples for conformation of microalbuminuria during 
3 consecutive days is more crucial than the choice of the immu- 
nological technique. 
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